Summaries per article with Clinical Psychology at Leiden University 22/23

Article summaries with Clinical Psychology at Leiden University

Summaries per article with Clinical Psychology at Leiden University 22/23

Image

Check summaries and supporting content in full:
Article summary of The Mental Status Exam Through Video Clips of Simulated Psychiatric Patients: an Online Educational Resource by Martin et al. - Chapter

Article summary of The Mental Status Exam Through Video Clips of Simulated Psychiatric Patients: an Online Educational Resource by Martin et al. - Chapter

What is the Mental status exam (MSE)? 

The Mental status exam (MSE) is used for symptom recognition of various mental illnesses during a psychiatric interview with a patient. The MSE utilizes the ABC-STAMPS approach, which stands for: Appearance, Behavior, Cooperation, Speech, Thought (this includes both thought process and thought content), Affect, Mood, Perceptions, and Suicidality. These nine facets of the patient are all assessed by the psychiatrist during the MSE. 

What were the methods used in the MSE study by Martin et al. (2019)?

Martin et al. investigated the effects of showing several video clips, which featured actors playing psychiatric patients, to both medical and nursing students. Multiple approaches have been used in the past in regards to teaching the MSE, including psychiatric interviews with actual patients, psychiatric interviews with simulated psychiatric patients (SPPs), documentaries and movies about mental illnesses, and online videos from university-level sources. The study by Martin et al. opted for showing clips of psychiatric interviews with SPPs as they found it to be the most accessible and ethically sound option. 

The researchers compiled 16 clips consisting of actors simulating 10 different common mental illnesses: depression, bipolar disorder, generalized and social anxiety, obsessive-compulsive disorder, borderline personality disorder, anorexia nervosa, schizophrenia, dementia, delirium, and opiate dependence/withdrawal. The 16 clips were shown during an hour-long lecture which also included information about the ABC-STAMPS approach. Afterward, students in the intervention group completed an online MSE assessment tool to evaluate their abilities to identify psychiatric symptoms seen in clinical interviews. Students in the control group completed the online MSE assessment without having previously attended the lecture containing the video clips. Additionally, all students were asked to answer questions about their knowledge of the MSE, ranking their perceived skills on a scale of 1-5. 

Martin et al. used the students’ scores on the MSE assessment tool as a dependent variable and didactic (whether students are in the intervention vs. control group) and discipline (medical degree vs. nursing degree) as two independent variables. They carried out a multiple linear regression, and using analysis of variance (ANOVA) they compared the MSE assessment scores between the intervention and control groups. 

What were the findings of the MSE study? 

The researchers found that the intervention group attained significantly higher scores on the MSE assessment than the control group. The effect of discipline on assessment score was not significant. Further, students’ subjective measurements of their MSE knowledge was not shown to be correlated with their score on the objective MSE assessment tool. 

The video clips showing psychiatric interviews featuring SPPs were therefore found to be an effective way to improve students’ knowledge of the MSE and their abilities to recognize psychopathological symptoms. One limitation of the study is that the students researched were all in preclinical university programs, so it is not possible to infer what the effects of the educational clips would be in the rest of the population.

Access: 
Public
Article summary of Anxiety, depression, and post-traumatic stress disorder in refugees resettling in high-income countries: systematic review and meta-analysis by Henkelmann et al. - Chapter

Article summary of Anxiety, depression, and post-traumatic stress disorder in refugees resettling in high-income countries: systematic review and meta-analysis by Henkelmann et al. - Chapter

What did this meta-study aim to achieve? 

This meta-analysis of 66 articles aimed to find the most accurate prevalence rates of anxiety, depression, and post-traumatic stress disorder (PTSD) among refugees who relocated to wealthy countries. Recent estimates for the prevalence of these disorders in refugees at the time of this meta-analysis were not available. Pooling the results of many studies was therefore needed to get an accurate picture of up-to-date prevalence estimates. In doing this, the analysis also aimed to understand both the potential causes of the differences in prevalence estimates (heterogeneity) between studies as well as the main factors responsible for anxiety, depression, and PTSD rates among refugees. 

Why is this issue important? 

The number of people in the world right now with refugee status is the highest it has been since World War Ⅱ. In addition to traumatic events often experienced in asylum seekers’ home countries and during their migration, refugees deal with high numbers of unemployment and loneliness once they have resettled in the new country. Identifying the causes of mental illness in refugees is crucial because of their high vulnerabilities. The more information that is known about mental illnesses in the refugee population, the more public health policies can be created and adapted to better support their needs once they are settled. 

How were the studies for the meta-analysis chosen? 

Using the information from 66 scientific articles, 150 prevalence estimates of depression, anxiety, and PTSD were selected. The articles that were included in the meta-analysis all utilized either semi-structured diagnostic interviews or questionnaires with validated cut-off scores to determine prevalence rates of anxiety, depression, and PTSD. All chosen articles also used their original data and figures. Finally, only refugees who had migrated into highly developed countries were included in any of the studies used by the meta-analysis. The studies used had to be conducted using the information from either the DSM-Ⅳ or DSM-Ⅴ. 

What prevalence rates for depression, anxiety, and PTSD were found? 

After analyzing the 150 prevalence rates from various studies, it was estimated that about 33% of the refugee population that has relocated to a highly developed country suffers from clinical PTSD and/or a depressive disorder. 10-20% of this refugee population is estimated to have a clinical anxiety disorder. The majority of the results from the studies were derived from self-report questionnaires, which were shown, on average, to produce slightly higher prevalence rates. Prevalences of all examined disorders (PTSD, depression, and anxiety) were significantly higher in refugees than in the general population. These results apply to children and adolescents as well as adults. Interestingly, the prevalence of these disorders was also significantly higher in refugees than among populations of adults living in war or high conflict countries. This result was not significant for children and adolescents. All results that were found apply to both males and females. 

Which factors predict depression, anxiety, and PTSD among refugees?

Multiple factors, such as familial separation, discrimination, unemployment, and prolonged asylum processes were shown to contribute to the prevalence of these mental disorders among refugees. Length of residency in the new country, the continent of origin, the continent of settlement, and the year the study was conducted were all found to have no statistically significant effect on the prevalence of mental disorders. Further, the prevalences did not change as a function of either age or gender. Notably, the factors that did raise the prevalence rates of these three disorders were characteristics of post-migration life. Since the length of residence was unrelated to mental illness prevalences, it may be that time on its own is not a sufficient factor for healing from the trauma of asylum-seeking or migration.

The refugee population is at a very high risk for developing PTSD, depression, and/or anxiety, even after they have been settled in a new country for many years. Therefore, it is of the utmost importance that future research is done on feasible prevention and treatment plans for mental illness in refugees, and action is taken by policymakers to implement these plans.

Access: 
Public
Article summary of Stress resilience during the coronavirus pandemic by Vinkers et al. - Chapter

Article summary of Stress resilience during the coronavirus pandemic by Vinkers et al. - Chapter

What are some common stress responses to the COVID-19 pandemic?

The immense amounts of psychosocial stress that have arisen in the population due to the current COVID-19 pandemic have largely been due to uncertainty regarding the future. Stress is a reasonable, normal, and adaptive response to the pandemic, especially considering that most people have never dealt with anything like it before. Some of the most common stress and stress-related patterns that have been observed in response to the COVID-19 pandemic are irritability, anxiety, reduced productivity and concentration, interpersonal conflicts, and insomnia.

What role does resilience play in coping with COVID-19? 

Many factors affect how well an individual can cope with major stressors, including the COVID-19 pandemic. One’s living conditions, access to healthcare, literacy, socio-economic status, and level of uncertainty about the future all contribute to the level of adaptation to the pandemic. Resilience, considered to be the opposite of vulnerability, can be used to cope with stress and stay balanced. The concept of resilience exists not only at the individual level but also at the community level.

How do the stress effects of the virus affect at-risk populations? 

Certain populations are at a higher risk to be affected by the negative results of COVID-19 related restrictions. The virus itself, fears surrounding becoming infected, and virus-related restrictions all can exacerbate mental illness or even trigger it. Those with psychiatric disorders who are already more prone to maladaptive stress responses now have less access to mental health care than usual. Healthcare workers must deal with the fear of getting the virus due to their proximity to COVID-19 patients. Feelings of failure have also been rising among healthcare workers who often face ethical issues surrounding COVID-19 patients and their families. Additionally, elderly people are particularly vulnerable to loneliness due to COVID-19 restrictions, especially because they are more often unable to communicate with smartphones and computers.

What interventions are most effective at increasing resilience? 

People have been shown to be more negatively impacted by stressors that they deem uncontrollable. It is up to the governments of nations to emphasize that COVID-19 is not an uncontrollable threat, but one that can be reduced through specific individual and community actions. The more that people acknowledge that the situation is controllable, the better they will be able to cope with its ensuing stress. Governments should also be clear about the pandemic-related information that they have and communicate it in a way that the general public, not just experts, can understand. Conversely, nationalism and unilateralism in decision-making will most likely only increase the stress-related impact of the pandemic on a given society. 

To promote resilience to the pandemic, governments, organizations, families, and workplaces should encourage social connectedness, self-care, planning everyday activities, exercise, good nutrition, and taking media breaks. Stress monitoring and team support can also help to lower the burden of the pandemic on healthcare workers. Resilience enhancing interventions for low socio-economic status individuals include assuring access to health and economic infrastructures and providing funds for those who are left without work due to the pandemic. Telemedicine approaches are helpful for those in need of regular mental health care. Finally, acquiring data on the psychosocial impact of the virus and the restrictions on COVID-19 patients and their families will provide a way to create interventions on the individual and community level that will increase resilience in the population.

Access: 
Public
Article summary of Mental illness is a result of misery, yet we still stigmatise it by Bentall - Chapter

Article summary of Mental illness is a result of misery, yet we still stigmatise it by Bentall - Chapter

In which ways is a purely biological approach to mental illness detrimental? 

The biological approach to identifying, diagnosing, and treating mental health disorders looks at mental illnesses as genetically determined brain conditions. A strict biological approach may hardly account for life experiences and trauma when considering the formation of psychiatric conditions. Mental health professionals and researchers who subscribe to the biological approach are often solely focused on finding the right medications for patients. However, research supports the idea that mental illnesses arise due to a complex interaction between an individual’s genes and their experiences in their environment. 

It has been shown that many mental disorders have much overlap, and are not biologically separate illnesses. Further, many people that are diagnosed with the same disorder will have entirely different paths and potential recoveries. For example, many people suffering from severe disorders like schizophrenia can make partial or, in some cases, full recoveries without taking any medication. Genetics do play a role in mental illnesses, but hundreds or even thousands of genes that are present in a person with a mental disorder are each only slightly to blame for the development of the illness. 

Finally, the biological approach to mental illness can increase stigmatization. If people think of mental illnesses as stemming solely from genetics and not from poor life circumstances, they may be more likely to categorize mentally ill people as “other”.

How can we better approach mental illness?

Environmental factors and trauma are often largely to blame for the development of a mental illness. According to research in recent years, these effects are so strong that they can alter brain structure. Instead of only being offered medication to combat the disorder, patients should have access to psychotherapy and practical advice counselors. Issues that commonly contribute to the development of mental illness in individuals are, among others, childhood poverty; inequality; physical, sexual, or emotional abuse; belonging to an ethnic minority; bullying, and separation from parents. 

Reducing the prevalence of mental illness in the population can likely be achieved by diminishing traumatic and damaging factors in childhood and adolescence. There are still many experience-related factors that could contribute to mental illness development that have not been studied because of the long-running biological focus of psychiatric conditions in the scientific community. While medications and genetic research prove helpful for some people with mental illnesses, addressing issues like childhood poverty will prevent many individuals from ever developing a mental illness at all. Society’s current portrayal of mental illness as a biological disease generally only helps to increase the stigmatization of mentally ill people. 

Access: 
Public
Article summary of Why Joker’s depiction of mental illness is dangerously misinformed by Driscoll & Husain - Chapter

Article summary of Why Joker’s depiction of mental illness is dangerously misinformed by Driscoll & Husain - Chapter

In what ways are the depictions of mental illness in Joker problematic? 

In recent years, awareness about more common mental illnesses like anxiety and depression has grown exponentially. Unfortunately, more severe disorders have seen no such growth in recognition. The portrayal of severe mental illnesses in popular media is still inaccurate and stereotypical. The 2019 movie Joker is one of the culprits of spreading this type of misinformation. A common stereotype about individuals with severe mental illnesses is that they are violent. Joker perpetuates this myth, as Arthur, the titular “joker”, grows more violent after stopping his medication. In actuality, people with severe mental illnesses are more susceptible to experiencing violence coming from others than are people in the general population, but they are not averagely more violent themselves. 

Joker is misinformative about the details of mental illnesses in more ways than one. Instead of selecting one psychopathology for the main character to suffer from, the writers of Joker seemed to pick and choose from symptoms that they found interesting and attribute them all to Arthur. Instead of representing symptoms that were plausible to occur together and that would perhaps portray one or two distinct mental illnesses, the movie used various and (seemingly) unrelated symptoms as plot devices.

What implications does Joker have for the real world? 

The effect of misinformation in popular media regarding mental illness has been seen before. One Flew Over the Cuckoo’s Nest, a 1975 film depicting the unethical use of electro-convulsive therapy, has been said to have created undue levels of mistrust around electro-convulsive therapy, which can be very effective as a treatment. Movies, (especially extremely popular and widely viewed ones like Joker) have to be held accountable for their representations of the severely mentally ill if the stigmatization around these disorders is ever to drastically improve. The misrepresentation of mental illness in Joker is misinformative at best and dangerous at worst. 

Access: 
Public
Article summary of Bipolar Disorder by Grande et al. - Chapter

Article summary of Bipolar Disorder by Grande et al. - Chapter

What is bipolar disorder?

Bipolar disorder is a recurring, chronic disorder that is characterized by fluctuations in mood and energy. It leads to cognitive and functional impairment. A distinction is made between type I and type II bipolar disorder. In bipolar I there must have been at least one manic episode. In bipolar II, there must have been at least one hypomanic and one depressive episode. Bipolar II is more common in women, for bipolar I the prevalence is equal among men and women. It is often diagnosed in young adults. This is the economically active population, which means that the social costs of the disorder are high. 

What are the characteristics of bipolar disorder?

Bipolar disorder is characterized by episodes of mania, hypomania, and depression. Bipolar II is often characterized by psychiatric comorbidity and suicidal behavior.

What are the characteristics of manic and hypomanic episodes?

Manic or hypomanic episodes are characterized by elevated mood and increased motor drive. With a manic episode there is an impairment of functioning, this does not have to be the case with a hypomanic episode. Occupational functioning is sometimes even improved during a hypomanic episode. Psychotic symptoms can occur during a manic episode. A hypomanic episode must last 4 days in a row, a manic episode must last 1 week. Specifiers define clinical features of episodes and the course of bipolar disorder. The rapid-cycling specifier, for example, indicates that there have been at least four episodes of mania, hypomania or depression within 12 months. The mixed specifier states that there are also three characteristics of the opposite spectrum during mania, hypomania or depression. If one of these specifiers is present, the prognosis of the disorder is worse.

What are the characteristics of depressive episodes?

The DSM-5 criteria for a depressive episode are the same for unipolar and bipolar disorders. Yet, there are other differences. Bipolar depression starts at a younger age, has more frequent episodes of shorter duration, has an abrupt beginning and end, is often comorbid with substance abuse, is triggered by stressors at early stages, and has more post-partum risk. Atypical symptoms are also more common. Somatic complaints are more common in unipolar depression.

What is the suicide risk?

The risk of suicide in bipolar disorder is 20 times higher than in the general population. Variables associated with suicide attempts include being a woman, early onset of disorder, depressive polarity of first and most recent episodes, comorbid anxiety and substance abuse disorders, borderline personality disorder, and a family history of suicide. Men succeed more often in their suicide attempts than women.

How fast is bipolar disorder diagnosed after onset?

The time between the onset of the disorder and diagnosis is 5-10 years on average. The most common comorbid disorders are schizophrenia, anxiety disorders, substance abuse, personality disorders and ADHD and ODD in children.

What causes bipolar disorder?

Bipolar disorder is one of the most heritable psychiatric disorders. A multi-factorial model in which both genes and environment interact fits the disorder best. Risk alleles overlap partly with those of schizophrenia.

What is the prognosis?

Bipolar disorder is often chronic and recurrent. Patients with a predominantly depressive polarity are most likely to commit suicide, and are often diagnosed with seasonal bipolar II. With mainly manic polarity, drug abuse and bipolar I are more common. Bipolar disorder is associated with neurocognitive deficits. Cognitive impairments in the areas of executive functions and verbal memory could at least partly explain functional impairments. Bipolar disorder is also often comorbid with cardiovascular diseases, diabetes and obesity.

What are the treatment options?

Various factors influence the choice of treatment, including medical and psychiatric comorbidity, past treatments, and the patient's willingness to be treated. Clinicians must take this into account to make the treatment as effective and efficient as possible. Mood stabilizers and antipsychotics are most commonly prescribed during acute bipolar mania or depression. The evidence for the effectiveness of antidepressants in treating depression is unclear. Electroconvulsive therapy is effective in patients with psychotic or catatonic characteristics. In general, antipsychotics are more effective than mood stabilizers, especially risperidone and olanzapine, because they work faster. A combination treatment of an atypical antipsychotic with a mood stabilizer is the most effective. During a depressive episode in bipolar I, antidepressants may only be prescribed in combination with a mood stabilizer. SSRIs and buproprion can be prescribed for bipolar II.
For long-term treatment, lithium is mainly used to prevent both manic and depressive episodes, whether or not in combination with an antipsychotic or antidepressant. Psychoeducation, cognitive behavior therapy, interpersonal therapy and social rhythm therapy are also effective.

Which are special populations to consider?

Which issues need to be considered during pregnancy?

Advice and guidance for women with bipolar disorder that want to get pregnant is important because some medication is harmful to the unborn baby. Women whose mood is stable sometimes stop taking medication abruptly when they become pregnant, which increases the risk of relapse. The reduction must be gradual. The risk of a relapse is particularly high in the post-partum period.

Which issues need to be considered for adolescents?

Early identification of bipolar disorder in adolescents aged 13-19 is crucial, as the disorder often presents itself before the age of 21. Attention should also be paid to the children of patients, because they have a greater risk of developing the disorder. The verbal expression of symptoms is constricted, because of cognitive and emotional immaturity of young people, making it more difficult to identify certain manic symptoms such as grandiosity and increased targeted activity. Some symptoms also overlap with ADHD, personality disorders and conduct disorders, making diagnostics more difficult.

Which issues need to be considered regarding physical health?

Medical comorbidity is common in bipolar disorder due to the effects of pharmacological treatments, genetic vulnerability and lifestyle factors (smoking, poor diet and lack of exercise). Physical health must therefore be checked upon regularly with these patients. When using lithium or valproate, blood concentrations should be monitored to ensure that they fall within the therapeutic range.

What does future research need to address?

Translational research is needed for a better pathophysiological understanding. This can also improve diagnostic accuracy, especially in young people.

Access: 
Public
Article summary of The levels problem in psychopathology by Eronen - Chapter

Article summary of The levels problem in psychopathology by Eronen - Chapter

What does the levels problem refer to? 

The levels problem in psychopathology refers to the fact that psychopathological disorders are investigated in different ways (or at different levels). Most frequently, these include the psychological level and the biological level. The boundary between these two levels is blurry, and it may be difficult at times to differentiate between them. For example, autism is not only a psychological disorder but also a biological one, so from what level should it be analyzed? As will be explained in the next section, there are also multiple different ways of categorizing levels. Since these categorizations have much overlap, levels should not be taken too literally, and should instead be used for heuristic purposes. The level problem makes it more difficult for researchers and clinicians to decide the best framework for advancing psychopathology research.

What are three ways of thinking about levels? 

Three common ways of conceptualizing different levels are the following: part-whole related levels, levels based on the scale of what is being measured, and levels based on the time range of what is being measured. Although these are not the only ways to think about levels, they are the most relevant in terms of psychopathology. To begin, part-whole levels refer to hierarchies, for example, within an organism. An organism can be broken down into tissues, cells, cell parts, molecules, and eventually atoms. The whole of an organism is at a higher level than that of its parts — thus, it is a hierarchical structure. This hierarchical system of levels, however, can vary even within the same organism, as what is considered a higher or lower level is determined by what is being measured. Additionally, the concept of part-whole levels is not always clear-cut. Ideally, there would be no overlap between levels in the hierarchy and no components that would fall between levels, but this is seldom the case in practice. There is also no agreed-upon way to decide with consistency which component belongs to which level in the part-whole system. 

Levels can also be thought of in terms of scales. Essentially, this means that the size of the thing being studied is what determines its level. The example of analyzing the activity of neurons is given in the article. In functional neuroimaging, each data point consists of millions of neurons, whereas cellular neuroscience analyzes neurons individually. In this case, the scale of functional imaging is much broader. Finally, there is the temporal scale, in which the length of the process being studied determined its level. For example, the interactions between brain areas take much longer than the interactions between neurotransmitters and receptors. Importantly, the temporal scale can be applied quite easily to the concept of psychopathology, because the time that it takes for symptoms and mental states to appear, progress, and fade can be measured and compared to the time it takes for neurobiological states to change.

What are explanatory reductionism and explanatory pluralism? 

People that take an extreme explanatory reductionist view believe that the neurobiological mechanisms of the brain make explanations at the psychological level useless. They think that the only reason psychological-level explanations are accepted as explanations at all is because we do not know the neurobiology behind those explanations yet. Those who subscribe to a more lenient version of explanatory reductionism believe that psychological explanations are real, but will never be as important or powerful as explanations on the neurobiological level. All explanatory reductionists think that biological explanations, which are on a lower level, are more useful than psychological explanations, which are on a higher level. This is partially due to explanatory reductionists’ reasoning that all behavior is merely an outward expression of biological activity, which in “mind-body debate” terms is a monism view. In past scientific research, it has often been very helpful to study the lowest biological levels. DNA, for instance, was discovered this way. However, it is not always sensible to ignore higher levels. In physics, for example, investigating only very low levels like molecules is not sufficient for actually explaining and predicting physical laws and behavior on a higher level. 

In the context of psychopathology, explanatory pluralism is more useful than explanatory reductionism. Explanatory pluralism advocates not just for exploring higher levels, but for investigating multiple levels (both higher and lower) in the context of one concept. Explanatory pluralism is most useful when the information received from each level is integrated into a more comprehensive system. Integrating all this information may mean that professionals from many fields have to compile and align concepts related to a specific psychological problem.

Why is examining psychopathology from a higher-level useful?

The field of clinical psychology relies on higher-level explanations of psychopathologies because it is exceedingly difficult to discover genes or other biological anomalies that wholly or substantially explain a specific psychiatric disorder. It is very unlikely that something as low level as a strand of DNA can ever explain something as high level and abstract as a mood disorder, for instance. On the other hand, researchers have made much progress in understanding the causes and subtypes of obsessive-compulsive disorder through analyzing the disorder's typical cognitive processes. Considering this, it would be prudent for psychopathological research to be done at multiple levels which differ in time, scale, and part-whole hierarchies. 

Access: 
Public
Article summary of On the Origins of Schizophrenia by Kahn - Chapter

Article summary of On the Origins of Schizophrenia by Kahn - Chapter

Why hasn’t the outcome of schizophrenia changed since the 1950s? 

Although there has been much research done on the etiology and treatment methods of schizophrenia since the 1950s, little progress has been made in terms of clinical outcomes. A few disheartening statistics demonstrate this well: the life expectancy of someone with schizophrenia is still almost 15 years shorter on average than that of a neurotypical person, and only 10% of people with schizophrenia will ever hold a job. However, medications that treat psychosis, the symptom most prominently associated with schizophrenia, are highly effective. In fact, after just 4 to 10 weeks of antipsychotic treatment, two-thirds of first-episode patients with schizophrenia do not show any signs of psychosis. 

Issues with consistent medication use in the schizophrenic population are partially to blame for the poor prognosis of schizophrenic patients in the long run. However, a unique hypothesis about this problem is proposed in this article; namely, that cognitive decline, not psychosis, should be the defining factor of schizophrenia. Psychologists Emil Kraepelin and Eugen Bleuler both believed that cognitive decline played a much more central role in schizophrenia than psychosis did. Since antipsychotics are so effective in controlling psychotic symptoms, but the prognosis for people with schizophrenia is not getting any better, it is logical to conclude that psychosis may be playing too large of a role in our current conception of schizophrenia.

What role does cognitive decline play in the development of schizophrenia? 

It has long been taught that schizophrenia begins in early adulthood. This conception has proven to be too simplistic. Foreboding signs of schizophrenia may begin a full 10 years or more before recognizable symptoms emerge. These signs are subtle, and consist of unusual cognitive, motor, and social behavior. Cognitive impairment, presenting as a lowered IQ, has been found to be quite a consistent similarity between children who later develop schizophrenia. This deficient IQ level can be seen long before psychosis emerges in the patient. Various longitudinal studies have found that relatively poor cognitive performance begins as early as age four in people who later develop schizophrenia. It is important to make the distinction that these strong links have been found between low cognitive ability and schizophrenia development, but not necessarily psychosis development.

How is abnormal brain maturation related to schizophrenia? 

After a groundbreaking study by Johnstone et al. was published in 1976, it has been known that patients with schizophrenia have reduced brain volume. More research has been done since, and it is clear that brain volumes are consistently smaller in patients with psychosis compared to neurotypical people. Further, studies were done on intracranial volume (ICV, also known as skull size) that showed that there were small but significant reductions in ICV in patients with schizophrenia versus controls. This is relevant because ICV is a very accurate indicator of brain expansion, meaning that patients with schizophrenia have stunted brain growth compared to the rest of the population. Some of this brain loss occurs far before symptoms of schizophrenia arise. In recent research concerning the brain-age gap (the difference between the actual age of a person and the examined age of their brain), it has been found that the brain age of schizophrenic patients is on average 3.6 years older than their chronological age. This abnormal maturation of the brain may begin whilst the patient is still an adolescent.

How do genetics affect the risk of developing schizophrenia? 

Schizophrenia was found to be a heritable disease shortly after it was defined as a disorder in the early 1900s. Genetics have been found to account for up to 85% of the risk of developing the disease. Using twin studies, it was found that 25% of the variance for the risk of developing schizophrenia was explained by cognitive impairment (lower IQ). Furthermore, 4% of the variance of lower IQ was itself explained by brain volume. Therefore, it can be concluded that abnormal brain development leads to cognitive deficits which play a large part in the genetic determination of developing schizophrenia. It is difficult for schizophrenia researchers to pin down the genetic causes of the disease on a more microscopic scale. Over 200 loci in the human genome have been implicated in increasing the risk of schizophrenia, however, each gene only accounts for a tiny proportion of genetic risk.

What should be the focus of future schizophrenia research be? 

The focus of schizophrenia research has long been on psychosis, as it has been seen as the diseases’ defining symptom for quite some time. Shifting the eye of schizophrenia research to cognitive decline during childhood and adolescence may help to identify cases earlier as well as help to improve the prognosis of schizophrenia which is currently a devastating disease in many ways. To study the cognitive decline in children who may develop schizophrenia in the future, it is important to put resources into large longitudinal studies that combine genetics, cognition, and brain imaging. This may also speed up the process of developing early interventions for youths who are at high-risk for the disease.

Access: 
Public
Article summary of Alice in Wonderland syndrome: A systematic review by Blom - Chapter

Article summary of Alice in Wonderland syndrome: A systematic review by Blom - Chapter

What symptoms comprise Alice in Wonderland syndrome? 

Alice in Wonderland syndrome (AIWS) was first described in 1955 by the psychiatrist John Todd, and its symptoms include various distortions of sensory perception, including visual distortions, and distortions of time and self. These distortions differ from hallucinations and illusions in the sense that they are based in the real world but involve very specific alterations to sensory input. AIWS currently comprises 42 visual symptoms (called metamorphopsias) and 16 non-visual symptoms. The two most common symptoms are micropsia; seeing things as smaller than they really are, and macropsia; seeing things as larger than they really are. 58.6% of AIWS patients suffer from micropsia while 45% suffer from macropsia. A few other visual symptoms include kinetopsia, in which people see stationary objects as moving, and prosopometamorphopsia, in which eyes are seen as much larger than they are. Symptoms sometimes include feelings of levitation and alterations in the passage of time, among others. It is most common for people with AIWS to only experience one symptom, although many people experience up to four. Generally, AIWS symptoms tend to be short-lived, lasting a few minutes to a few days. Years-long or lifelong symptoms occur rarely.

What are the causes of AIWS? 

There are many possible causes of AIWS, and more will likely be added as more cases are identified. The causes differ between young people and adults. For youths, the most common cause of AIWS is encephalitis (inflammation of brain tissues). Encephalitis can be caused by various infections, but the Epstein-Barr virus is the one most frequently cited in cases of encephalitis-induced AIWS. In adults, neurological disorders were cited most often as the medical cause for AIWS, with migraines being the most common among them. However, symptoms of AIWS are sometimes unassociated with any type of medical disorder or pathology. Symptoms of this syndrome are caused by functional and/or structural abnormalities in the perceptual system.

What are the prevalences of AIWS in the population? 

Although AIWS is thought of as a rare syndrome, some of its symptoms are seen quite regularly in the general population. In fact, singular symptoms of AIWS unrelated to another disorder or medical condition have been experienced by around 30% of all adolescents. When considering specific symptoms, it was found that 5.6% of male adolescents and 6.2% of female adolescents have experienced micropsia and/or macropsia. It was also found that 15% of patients with migraines suffer from AIWS.

What are the treatment methods and prognoses for AIWS? 

Patients with AIWS often suffer from underlying medical conditions like encephalitis, migraines, or epilepsy. When this is the case, pharmacological treatment is used in an attempt to diminish or eliminate the underlying cause. Typically, medication is only necessary in medically-induced cases, and this treatment must target the medical condition rather than the symptoms themselves. Generally, these treatments include antiepileptic medication, antibiotics, antiviral medication, or migraine medication. Oftentimes in medical cases of AIWS, symptoms disappear and return in coordination with the severity of the disease at the time. In most cases of non-medically-induced AIWS, a helpful treatment can consist merely of reassurance from a clinician that the symptoms they are experiencing are benign. Chronic cases may warrant functional neuroimaging to better understand specific symptoms. Almost all cases of AIWS are considered benign and treatable, as full remission of symptoms is often achieved both in medically-induced and non-medically induced cases. This can occur either spontaneously or after treatment. However, the prognosis for patients with epilepsy or migraine-induced AIWS is poorer — these patients rarely achieve full remission due to the difficulty of treating their underlying conditions.

Why is AIWS so regularly discounted in scientific literature and clinical practice? 

It is estimated that AIWS is severely underdiagnosed. This is partially due to its apparent similarities to schizophrenia spectrum disorders, as patients’ perceptual distortions may be attributed to hallucinations. The diagnosis of AIWS is also made more difficult because it is not featured in either the DSM-5 or the ICD-10. In practice, symptoms of AIWS may not be recognized because of this factor. It is suggested that AIWS should be included in the next versions of the DSM and ICD under the categorization of nervous system disorders or perceptual disorders. An international database that documents cases of AIWS and their treatments would also be extremely helpful for clinicians trying to learn about and diagnose this syndrome.

Access: 
Public
Article summary of The network approach to psychopathology: a review of the literature 2008-2018 and an agenda for future research by Robinaugh et al. - 2020 - Exclusive
Article summary of Drug Tolerance, Drug Addiction, and Drug Anticipation by Siegel - Chapter

Article summary of Drug Tolerance, Drug Addiction, and Drug Anticipation by Siegel - Chapter

How does Pavlovian conditioning work in the context of addiction? 

It has been known for decades that addicts experience symptoms of drug withdrawal when they encounter situations or environments that they associate with their drug use. Just the sight of drug paraphernalia or speaking about drugs to other people can elucidate these symptoms. This is due to Pavlovian (or classical) conditioning. In Pavlovian conditioning, there are unconditional and conditional stimuli, as well as unconditional and conditional responses. In the context of drug use, the unconditional stimulus is the pharmacological effect of the drug. The drug induces a compensatory response in the body. For example, alcohol has a temperature-lowering effect, so after ingestion, the body raises its temperature to compensate. The cues or environment accompanying the administration of the drug are the conditional stimuli, which need to be associated with the effects of the drug multiple times before being effective in elucidating withdrawal symptoms. Eventually, these cues (the conditional stimuli) will bring about conditional compensatory responses. These conditional compensatory responses also counteract the drug effect, even when no drug was administered.

What factors influence the strength of an addict’s tolerance? 

An addict’s tolerance to a certain drug increases when, due to repeated use, the drug’s effect on their body decreases. The more that the conditional compensatory response strengthens, and thus the drug’s effects are more highly counteracted, the higher someone’s tolerance will be. Situational specificity of tolerance is a concept that illustrates the effects of the specific environment (conditional stimuli) on drug tolerance levels. In experiments designed to demonstrate situational specificity of tolerance, people are administered drugs in the exact same environment multiple times in the tolerance-development phase. After, in a tolerance-test session, the participants are split up into two groups. One group is administered drugs in the same environment as before, and one group’s drug administration environment changes. Those in the unchanged environment will show heightened tolerance to the drug due to the conditional stimuli (the environmental cues). However, those in the changed environment will show lowered tolerance, and the effect of the drug on them is stronger than it was at the end of the tolerance-development phase. For example, college students have been shown to display less alcohol tolerance when they consume a familiar alcoholic beverage than when they consume an unfamiliar, peppermint-flavored blue beverage with the same alcohol content. This situational specificity of tolerance has also been shown to apply to potentially lethal doses of drugs.

What causes symptoms of withdrawal? 

Withdrawal symptoms are caused by conditional compensatory responses when there is no drug provided after the conditional stimuli. In other words, if a drug is not administered after the typical stimuli that precede drug use, withdrawal symptoms begin. The feeling of withdrawal is simply the compensatory response reaching its full expression because there is no drug effect to counteract it. It is important to note that the anticipation of drug use is what causes withdrawal, not the drug itself. In addition to drug compensatory responses, these withdrawal symptoms can also manifest as neurochemical responses which are felt as cravings. 

What are the different types of drug-related cues? 

There are two broad categories of cues when it comes to the Pavlovian conditioning of drugs: exteroceptive and interoceptive cues. Exteroceptive cues, which are more commonly used in experiments, are those that can be seen, heard, or smelled by both the experimenter and the subject. Interoceptive clues are those that only the subject is aware of which become associated with the administration of a drug. Within interoceptive cues, there are self-administration cues and drug-onset cues. Self-administration cues refer to the ritual that one participates in while administering themselves the drug, such as injecting themselves with a drug intravenously. This kind of cue will also function as a conditional stimulus, bringing about a conditional compensatory response. It has been shown that tolerance is higher after one goes through their typical self-administration procedure than when they are administered the same amount of the drug by an experimenter. Drug-onset cues describe the immediate effect of a drug before its full effect comes through. Drug-onset cues, such as the warm feeling that alcohol tends to immediately elicit, consistently precede the stronger effects of the drug. In rats, it has been shown that administering a small dose of a drug elicits symptoms of withdrawal when the full and expected dose is not then provided. The rats had associated the drug-onset cues with the eventual full drug effect. 

What are the implications of these findings for addiction treatment? 

Behavioral therapies for drug addiction can utilize Pavlovian conditioning. In these therapies, predrug conditional cues can be extinguished by presenting the addict with the conditional cue and denying them access to the drug. It would be helpful to incorporate interoceptive drug cues, including memories, emotions, and cognitions into the pool of conditional predrug cues. Accurate insight into the possible predrug cues for the addict, both exteroceptive and interoceptive, will allow for the most effective drug addiction treatment.

Access: 
Public
Article summary of The Heroin Overdose Mystery by Siegel - Chapter

Article summary of The Heroin Overdose Mystery by Siegel - Chapter

What are some common explanations for heroin overdoses? 

Heroin overdose is a pressing issue, with about 1 to 3% of heroin users dying from an overdose every year. In the United States in 2011, almost 11,000 people died from a heroin overdose. Accurate explanations are needed for why some addicts overdose so work can be done to reduce heroin-related deaths. One reason often given for these deaths is that the addict had taken other drugs in coordination with heroin. Heroin is a central nervous system depressant drug, so its combination with other depressants (like alcohol) can sometimes be fatal. However, most cases of heroin overdose are not due to drug mixing. 

A second reason cited frequently as a cause for a heroin overdose is that addicts lose tolerance after abstaining from using the drug for a long period. According to this theory, when the addicts eventually use heroin again the drug will have a much stronger effect on their body, potentially resulting in overdose. Yet, there is evidence to suggest that drug tolerance in humans does not deteriorate after months or even years of abstaining from use. This can be shown using segmental hair analysis because temporal patterns of drug use can be seen by examining an individual’s hair. Based on the hair strands of recently deceased overdose victims, researchers have found that there is no link between recent abstinence and overdose. 

What is the heroin overdose mystery? 

The heroin overdose mystery refers to the fact that there is often no obvious reason for why an addict overdoses on a specific day. Post-mortem procedures for overdose victims include measuring the amount of morphine in the blood (because morphine is the metabolized version of heroin). It has been found that morphine levels in the blood of overdose victims are often — about 75% of the time — no higher than other heroin users who have not overdosed. Considering this, it is concluded that the causal factor of death by heroin overdose is not typically the actual amount of the drug in the body. In fact, in many cases, it has been noted that the overdose victim used the same amount of heroin the day before, and it was non-fatal. Simply put, many (if not the majority) of heroin “overdoses” are not true pharmacological overdoses. There is clearly another factor at play, and many theories have been suggested for what exactly that factor is; this article argues that it is due to the Pavlovian conditioning of drug users. 

What is the Pavlovian conditioning explanation for heroin overdoses? 

The theory of Pavlovian conditioning in the context of heroin overdoses is based on the finding that most overdoses occur in drug-administration environments that are new to the addict. In Pavlovian conditioning, there is a conditional stimulus, a conditional response, an unconditional stimulus, and an unconditional response. Concerning drug use, the unconditional stimulus is the drug itself, while the unconditional response is the homeostatic counter-response to the pharmacological effect of the drug on one’s body (for example, if the drug decreases heart rate, the homeostatic response would increase heart rate to counter the effect of the drug). The conditional stimulus, on the other hand, is the setting in which the drug is administered, and the conditional response is again the homeostatic counter-response, which this time occurs in anticipation of the drug’s effect. These homeostatic counter-responses to the drug lower its effects and lead to acute tolerance (a decrease of the drug’s effect during the span of one drug administration). 

Chronic tolerance is obtained after repeated use of a drug and is mediated by the conditional, drug-effect-decreasing response. This conditional-response can be life-saving. When in novel drug-administration settings, chronic tolerance will not be displayed due to an absence of the conditional response. The body will not produce the conditional (drug-counteracting) response because it is not paired with the conditional stimulus (the typical drug-administration setting). Therefore, whether or not a heroin user suffers an overdose is highly contingent on whether the drug is being administered in a familiar or novel environment. This effect has been replicated several times in experiments with both animals and humans. 

The rate of death from drug overdoses in the United States is about one and a half times as high as is the rate of death from automobile accidents. Heroin is the drug most commonly to blame for these overdoses. Most heroin users are unaware that ingesting the drug in an unfamiliar environment is very dangerous. Certainly, mere knowledge of this fact could save many lives.

Access: 
Public
Article summary of Treatment of anxiety disorders by Bandelow et al. - Chapter

Article summary of Treatment of anxiety disorders by Bandelow et al. - Chapter

What are the prevalences and causes of anxiety disorders? 

As a group, anxiety disorders are the most common mental health disorders, and they often greatly diminish quality of life. In the DSM-5, the following disorders are listed under anxiety disorders: panic disorder (PDA), agoraphobia, generalized anxiety disorder (GAD), social anxiety disorder (SAD), specific phobias, separation anxiety disorder, and selective mutism. Specific phobias are the most common anxiety disorder, displaying a 12-month prevalence of 10.3% in the general population. PDA is the second most common, with a 12-month prevalence of 6%. SAD and GAD are the third and fourth most common anxiety disorders, with 2.7% and 2.2% 12-month prevalence rates, respectively. Generally, anxiety disorders are chronic, and symptoms fluctuate back and forth over time. However, the only anxiety disorder that still shows up frequently in adults over the age of 50 is GAD. Women are diagnosed 1.5 to 2 times more often with an anxiety disorder than men are. Anxiety disorders are frequently comorbid with depression, personality disorders, and other anxiety disorders. 

Anxiety disorders are thought to be caused by an interaction between a genetic predisposition to the disorder and environmental factors, such as stress, trauma, or adversity during childhood. Although much research has been done, no genetic biomarkers specific to anxiety disorders have been found. 

How are anxiety disorders treated?

Anxiety disorders are commonly treated with psychotherapy, pharmacologically, or a mixture of both. The patients with anxiety disorders who seek help most often suffer from GAD, PDA, and/or SAD. Treatment is not always needed in mild cases, but daily impairment due to the disorder indicates a need for intervention. In rarer cases, patients may need to be hospitalized due to suicidal tendencies, comorbidities, or extreme unresponsiveness to treatment. Patients suffering from certain anxiety disorders (specifically, PDA) are much more likely to seek treatment than those suffering from specific phobias. This may have to do with the perceived severity and imminency of the consequences of a panic attack. Conversely, those with specific phobias might not realize they have a treatable disorder. It had been found that as a group, anxiety disorders go untreated very frequently, with only about 20% of those with an anxiety disorder ever seeking treatment. 

What drugs are used to treat anxiety disorders? 

There are many drugs available to treat anxiety disorders. Selective serotonin reuptake inhibitors (SSRIs) and selective serotonin norepinephrine reuptake inhibitors (SNRIs) are both antidepressants usually prescribed as the first line of defense against anxiety disorders. These drugs are very effective, yet their tendency to increase anxiety symptoms within the first few weeks of treatment may hinder treatment compliance. Because of this, patients are often started at a lower dose of the drug, and work their way up to a higher dose. Many studies show that SSRIs are better tolerated than SNRIs. Withdrawal reactions to SSRIs are possible but unlikely. 

Pregabalin, a calcium modulator, has a sedative effect which is helpful for those with anxiety disorders and a comorbid sleep disorder. This drug works more quickly than antidepressant anxiety drugs but withdrawal is more of an issue. Tricyclic antidepressants are as effective as SSRIs and SNRIs but are associated with more frequent adverse effects. Tricyclic antidepressants should not be used as a first-line defense against anxiety disorders. 

Benzodiazepines are also not recommended for first-line treatment, although they are effective drugs in combatting anxiety disorders. The effects of benzodiazepines are more immediate than the anxiety-soothing effects that come from antidepressants, but they are associated with central nervous system depression, which can cause many adverse effects. Benzodiazepines can be used in coordination with other anxiety-reducing drugs in severe cases, or during the weeks after starting an SSRI or SNRI before it kicks in. 

Drug treatment for anxiety disorders should be continued for at least 12 months after the apparent remission of symptoms in a patient. When the patient does terminate the drug plan, their dose should be tapered off over 2 weeks so as to not cause withdrawal symptoms or other unwanted effects. 

How effective is therapy in psychotherapy in treating anxiety disorders? 

In contrast to drug treatment of anxiety disorders, everyone who suffers from anxiety could benefit from psychotherapy. Cognitive-behavioral therapy (CBT) is especially effective. For those with phobias, exposure therapy techniques are often effective and should be included in treatment. Only 1 to 5 therapy sessions using exposure techniques have been shown to effectively treat phobias. While psychotherapy can be extremely effective in treating anxiety disorders, medication has a stronger pre-post treatment effect size. The effect of therapy on reducing the symptoms of anxiety disorders is similar to that of taking a placebo drug said to treat anxiety. This points not to the relative weakness of psychotherapy but rather the relative strength of a medication-based placebo effect. Both drug treatment and psychotherapy can have a major impact on those suffering from anxiety disorders.

Access: 
Public
Article summary of Cognitive-behavioral therapy for generalized anxiety by Borza - Chapter

Article summary of Cognitive-behavioral therapy for generalized anxiety by Borza - Chapter

What is generalized anxiety disorder (GAD)?

Generalized anxiety disorder (GAD) affects about 6% of the population and is characterized by excessive worry about various topics, and an inability to tolerate uncertainty. This worry has to occur more often than not over a time period of at least 6 months in order to get a diagnosis. Often, the worries that people with GAD experience are simply much more intense versions of the same worries that the general population grapples with. People with GAD may also have issues with sleeping and restlessness or concentration difficulties. Another core symptom in GAD is the constant searching for reassurance. Comorbidities with GAD are very common — about 66% of patients with the disorder present with at least one other psychopathology. It is estimated that about 90% of people with GAD suffer from at least one additional anxiety disorder. The diagnosis has evolved quite a bit over the last 20 years, and it is expected that GAD will become a more specific and individualized disorder in the coming years. 

How can GAD be represented through various models? 

Barlow’s model refers to the psychological vulnerability that sufferers of GAD have to adverse life events. This theory posits that people with GAD focus on potential threats in their lives and perceive a loss of control over their life. The model of intolerance of uncertainty postulates that people with clinical anxiety have difficulty coming to terms with the potential negative outcomes of future events. These individuals create positive beliefs about their worries; they may believe that if they do not suffer any consequences of a particular event that their worries have “worked”. Some of these chronic worriers tell themselves that an accident is more likely to happen if they stop worrying. This coping strategy will not work in their favor — the worry will always come back. 

What are some interventions for GAD? 

With functional analysis, clinicians can get a good idea of how, when, and why an anxious response is triggered in a patient with GAD. This method makes it easier for the therapist to understand the patient’s cognitions and mental state. Psychoeducation is also a common and effective tool. This entails educating patients about therapeutic instruments that can be used to help them and has been found to increase patients’ motivations to improve their symptoms. In the emotional/behavioral approach, the patient is taught how to generate positive emotions. They will also be given the chance to be exposed to their own emotions, which should help to habituate them. Through exposure, patients should be able to better process and tolerate their own fears. The cognitive perspective emphasizes recognizing thoughts and discerning them from emotions. This therapy method also focuses on altering the patient’s thoughts to be more objective and less emotional and less subject to cognitive biases. 

Access: 
Public
Access: 
Public

Image

This content refers to .....
Psychology and behavorial sciences - Theme
Click & Go to more related summaries or chapters

Study Guide with article summaries for Clinical Psychology at Leiden University

Join WorldSupporter!
This content is related to:
Psychology and behavorial sciences - Theme
Check more of topic:
Search a summary

Image

 

 

Contributions: posts

Help other WorldSupporters with additions, improvements and tips

Add new contribution

CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Image CAPTCHA
Enter the characters shown in the image.

Image

Spotlight: topics

Check the related and most recent topics and summaries:

Image

Check how to use summaries on WorldSupporter.org

Online access to all summaries, study notes en practice exams

How and why use WorldSupporter.org for your summaries and study assistance?

  • For free use of many of the summaries and study aids provided or collected by your fellow students.
  • For free use of many of the lecture and study group notes, exam questions and practice questions.
  • For use of all exclusive summaries and study assistance for those who are member with JoHo WorldSupporter with online access
  • For compiling your own materials and contributions with relevant study help
  • For sharing and finding relevant and interesting summaries, documents, notes, blogs, tips, videos, discussions, activities, recipes, side jobs and more.

Using and finding summaries, notes and practice exams on JoHo WorldSupporter

There are several ways to navigate the large amount of summaries, study notes en practice exams on JoHo WorldSupporter.

  1. Use the summaries home pages for your study or field of study
  2. Use the check and search pages for summaries and study aids by field of study, subject or faculty
  3. Use and follow your (study) organization
    • by using your own student organization as a starting point, and continuing to follow it, easily discover which study materials are relevant to you
    • this option is only available through partner organizations
  4. Check or follow authors or other WorldSupporters
  5. Use the menu above each page to go to the main theme pages for summaries
    • Theme pages can be found for international studies as well as Dutch studies

Do you want to share your summaries with JoHo WorldSupporter and its visitors?

Quicklinks to fields of study for summaries and study assistance

Main summaries home pages:

Main study fields:

Main study fields NL:

Follow the author: Psychology Supporter
Work for WorldSupporter

Image

JoHo can really use your help!  Check out the various student jobs here that match your studies, improve your competencies, strengthen your CV and contribute to a more tolerant world

Working for JoHo as a student in Leyden

Parttime werken voor JoHo

Statistics
273